| Name | Title | Contact Details |
|---|
Otsego Memorial Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Gaylord, MI. To find more information about Otsego Memorial Hospital, please visit www.myomh.org
Diversified Radiology of Colorado is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Denver, CO. To find more information about Diversified Radiology of Colorado, please visit www.divrad.com
Serving Virginia's Eastern Shore with five medical centers and four dental locations from Chincoteague Island to Cape Charles, Eastern Shore Rural Health System, Inc. (ESRHS), is the medical provider of choice for more than half the Eastern Shore community's population. All ESRHS centers are open Monday - Friday with evening hours available including 10-hour days at the Onley center. ESRHS is open on Saturday mornings year-round at the Onley center and seasonally at Chincoteague. In addition to primary medical and dental services, ESRHS offers health education, pharmacy assistance, digital x-ray, labwork, travel immunizations and much, much more. In partnership with the Chesapeake Bay Bridge-Tunnel, ESRHS is able to offer toll passes for qualifying residents who have a medical visit with a specialist. ESRHS' electronic health records system means you can be seen at any ESRHS center and the staff will have your complete medical history. ESRHS' highly qualified clinicians offer compassionate, dedicated care for their patients. At ESRHS you are more than just a medical chart, you're a part of a family-oriented medical home. In one year's time 28,483 people chose one of Rural Health's five medical locations or four dental locations for their healthcare needs. We provided 92,712 medical and 13,606 dental visits. This past fiscal year, 29% of Rural Health patients had private insurance; 19% had Medicaid; 14% had Medicare; and 38% were uninsured.
intellyst Medical Communications is a Aurora, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.